Exelixis Inc
(NAS:EXEL)
$
36.115
0.265 (0.74%)
Market Cap: 10.31 Bil
Enterprise Value: 9.21 Bil
PE Ratio: 23.15
PB Ratio: 4.54
GF Score: 91/100 Exelixis Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 15, 2022 / 06:00PM GMT
Release Date Price:
$20.3
(-1.41%)
Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
Hello, everyone, and welcome to Oppenheimer's 32nd Annual Healthcare Conference. I'm Jay Olson, 1 of the biotech analysts at Oppenheimer, and I want to thank you for joining us here today. It's my pleasure to welcome Exelixis to our conference, and it's an honor to introduce Michael Morrissey, President and CEO. Thank you so much, Michael, for joining us here today. It's really a pleasure to catch up with you.
I want to remind our audience that if they have any questions during the discussion, they can please feel free to submit them using the Q&A function. And with that, we'll go ahead and get started. I thought maybe we could open up with a focus on cabo. It's a great year...
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
Sounds good.
Questions & Answers
Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
It was a great year,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot